Comparing Telepractice and Conventional Face-to-face Voice Therapy

February 25, 2020 updated by: Chi-Te Wang, Far Eastern Memorial Hospital

Voice Therapy for Benign Voice Disorders in the Elderly: A Randomized Controlled Trial Comparing Telepractice and Conventional Face-to-face Therapy

People over 55 years are high-risk with voice disorders. Voice disordered elderly need vocal training in order to improve communication efficiency and quality of life. However, participation in vocal training of elderly is often restricted by motivation, time of practice, and availability to hospital, which thus reduces treatment effects. The purpose of the study is to design a telecommunication vocal training system and a vocal training program for voice disordered elderly in Taiwan. The investigator proposed a 3-year consecutive study, including a single-blind, randomized controlled trial, to test the hypothesis that vocal training via telepractice for voice disordered elderly are not inferior to the standard face to face training.

Study Overview

Detailed Description

Randomization: per mutated block, 40 patients on each arms (experimental and control)

Allocation: sealed envelope indicating either of the 2 groups

Intervention: weekly vocal training, each course last for 30-40 minutes,lasting for 2 months

Outcome measurement: before treatment, 1 month, 3 months, and 6 months after treatment

Primary outcome: 10-item voice handicap index

Secondary outcome: acoustics and aerodynamic parameter

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • patient equal or older than 55 years old
  • Voice Handicap Index-10 (VHI-10) score >10 point
  • accessibility to a network connection

Exclusion criteria

  • neurologic disorders
  • active pulomanory disease
  • mental disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental
Vocal Training via Telepractice
Vocal Training Via Telepractice, delivered by integrated communication service
Active Comparator: control
Vocal Training via face-to-face practice
Vocal Training Via face-to face practice at medical facilities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline of 10-item voice handicap index at 2 months
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
min: 0(best); Max: 40(worst);
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceptual Analysis using grade, roughness, breathiness, asthenia, and strain
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
from 0(best) to 3(worst)
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
Jitter
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
percentage of jitter based on continuous vowel
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
Shimmer
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
decibel (dB) of shimmer based on continuous vowel
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
Noise to harmonic ratio
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
Noise to harmonic ratio based on continuous vowel
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
smoothed Cepstrum peak prominence
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
based on reading a Mandarin passage
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
Maximal phonation time
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
seconds
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
VLS
Time Frame: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
Videolaryngostroboscopy (mucosal wave: normal, mildly decreased, severely decreased, absent)
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chi-Te Wang, MD, PhD, Department of Otolaryngology, Far Eastern Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 17, 2016

Primary Completion (Actual)

December 19, 2018

Study Completion (Actual)

December 19, 2018

Study Registration Dates

First Submitted

September 23, 2016

First Submitted That Met QC Criteria

September 30, 2016

First Posted (Estimate)

October 4, 2016

Study Record Updates

Last Update Posted (Actual)

February 26, 2020

Last Update Submitted That Met QC Criteria

February 25, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aged

Clinical Trials on Vocal Training Via Telepractice

3
Subscribe